Why Clinically Validated BP Devices Matter for Hypertension Control - Webinar Series

8 May 2026
Highlights
Reading time:

Organized by

Department of Health Promotion and Disease Prevention and Control, WHO South-East Asia Regional Office

Why clinically validated BP devices matter most

  • Accurate measurement of blood pressure influences the effective diagnosis, treatment, and long-term management of hypertension.
  • Most devices in the market and clinical settings are not validated.
  • Clinically validated automated BP measurement devices plays significant importance for achieving SEAHEARTS milestone to place 100 million people with hypertension on protocol-based management, with at least 60 million achieving controlled blood pressure by 2030.

Target audiences:

  • National programme managers (primary health care, NCDs, UHC, Health systems, Health technology)
  • Hospital and facility managers
  • Medical device regulatory authorities
  • Public procurement authorities and agencies
  • Healthcare providers and clinicians
  • Nongovernmental organization
  • Academic institutes
  • Any interested personnel

Webinar objectives

  • to build awareness and understanding on importance of improving access and promote use of clinically validated blood pressure measuring devices.
  • to discuss and drive actions for national policies and procurement practices, and accelerating the adoption of validated BP devices into national health systems.

Webinar registration link:

https://who.zoom.us/webinar/register/WN_NPHQg9qfQq-yIUZ2UYJCyQ

Upon completing your registration, you will receive a confirmation email containing detailed instructions for joining the webinar.